Part of the debate – in the Senedd at 3:12 pm on 25 October 2022.
Thank you for the statement. I'm eager to confirm the strong support of these benches to vaccination programmes in general and their contribution to the nation's health. In a way, it's strange, whilst welcoming the new framework, that we didn't have a framework previously, because vaccination is such an important a part of the health landscape in Wales. But, we have been through a period where more focus has been placed on vaccinations than at any other time in our history, given the pandemic. One question on the pandemic vaccination programme. The Government said that the autumn booster programme is progressing well, but the figures do suggest that the uptake is lower than it has been, particularly among the immunosuppressed. So, I wonder whether the Minister could look into or give a commitment to look into why the uptake seems to be so much lower this autumn.
But to return to the statement in more general terms, I think the six focus areas are sensible. I particularly welcome the focus on aiming for a system where everyone has equal access to vaccination, because at the moment, as the Minister has said, that isn't the case.
I want to focus on one thing particularly here. The statement refers to the intention to create a central procurement system for flu vaccination from 2024 onwards. At the moment, surgeries procure their own vaccinations directly from suppliers. Scotland has already said that they will turn to a central procurement system, where health boards buy all of the vaccinations and distribute them locally. Now, whilst there are benefits to moving to a centralised system such as this one for the longer term, I think it is important, at this early stage in the discussions, to bear in mind the challenges that are very likely to arise, and we know that from the Scottish experience. When Scotland introduced the system, they realised that (1) it would take a period of around three years to introduce such a system, but, secondly, that it would have a negative impact on pharmacies—or, rather, surgeries. In responding to that uncertainty, what the Scottish Government did was to provide an additional £5 million to ensure that the process not only accelerated and happened effectively, but also compensated surgeries during that initial period. So, can I ask whether the Minister will give a commitment to work closely with GPs and surgeries to find ways of mitigating those possible negative impacts, if this is introduced? And also will she agree to consider following the Scottish example and providing particular financial support where required?